Natural disease course modeling of achondroplasia to evaluate the efficacy of recifercept in the absence of a placebo control arm in phase II study
Abstract While randomized, placebo‐controlled, double‐blinded clinical studies are the gold standard for evaluating the efficacy of investigational drugs, the use of placebo in children with achondroplasia should be limited because it provides no clinical benefit while exhausting study participants&...
Saved in:
Main Authors: | Wenlian Qiao (Author), Martin Boucher (Author), Alison Slade (Author), Vikas K. Dawra (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Achondroplasia and its oral manifestations
by: P N Nanmaran, et al.
Published: (2023) -
The first drug for the treatment of children with achondroplasia
by: article Editorial
Published: (2021) -
Extensive Limb Lengthening for Achondroplasia and Hypochondroplasia
by: Dror Paley
Published: (2021) -
Achondroplasia: Craniofacial manifestations and considerations in dental management
by: Afnan Al-Saleem, et al.
Published: (2010) -
Prenatal Diagnosis of Concurrent Achondroplasia and Klinefelter Syndrome
by: Esther Perez-Carbajo, et al.
Published: (2015)